ArticleInternational journal of hematology-oncology and stem cell research2018

A Double-Blind, Randomized Comparison Study between Zytux™ vs MabThera® in Treatment of CLL with FCR Regimen: Non-Inferiority Clinical Trial.

Gholamreza Toogeh et al.PubMed ↗Full text ↗

No numbers read from the abstract.